Menu

Press Releases

Date Summary View
Toggle Summary Egalet and RedHill Biopharma enter into License Agreement
Egalet and RedHill Biopharma enter into an exclusive license agreement to develop, and commercialize Egalet’s EG-P042 (Carvedilol) for the treatment of certain cardiac diseases ...
View HTML